Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06618586 · ClinicalTrials.gov registry record · NA
Get Social Media and Risk-Reduction Training
A NA study of Infant Death and Sudden Infant Death, sponsored by University of Virginia.
- Recruiting
- Registry status
- NA
- Development phase
- 10,000
- Enrollment target
- 1
- Study location
NCT06618586: Recruiting NA study of Infant Death and Sudden Infant Death, sponsored by University of Virginia.
NCT06618586 is a NA study of Infant Death and Sudden Infant Death that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 10,000 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (613% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06618586, a NA study of Infant Death and Sudden Infant Death, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- NA
- Development phase
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the implementation of the TodaysBaby™ mobile safe sleep intervention program in US hospitals. The main aims of this study are to examine: 1) differences in program penetration and the equity of penetration according to income and race/ethnicity; 2) differences in feasibility, acceptability, sustainability and fidelity top the intervention; and 3) the effectiveness of the intervention.
Primary Outcome
Rate of sign up for TodaysBaby among mothers that sign up during the different implementation strategies
Conditions Studied
Interventions
- BEHAVIORAL TodaysBaby
Study Locations (1)
Massachusetts
- Boston University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
What NCT06618586 shows while recruiting
NCT06618586 is an interventional study that assigns participants to a tested intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (613% higher).
The record links to 2 conditions, with Infant Death appearing as the primary indexed condition, and to 1 intervention - of which TodaysBaby is the first listed.
NCT06618586 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06618586 about?
NCT06618586 is a clinical study titled "Get Social Media and Risk-Reduction Training". This study examines the implementation of the TodaysBaby™ mobile safe sleep intervention program in US hospitals. The main aims of this study are to examine: 1) differences in program penetration and the equity of penetration according to income and race/ethnicity; 2) differences in feasibility, acc...
What is the current status of trial NCT06618586?
This trial is currently recruiting. It is a NA study. The enrollment target is 10,000 participants. The study started on 2025-05-01. Estimated completion is 2028-06-01.
What conditions does trial NCT06618586 study?
This clinical trial studies the following conditions: Infant Death, Sudden Infant Death.
What interventions are being tested in trial NCT06618586?
The interventions under investigation include: TodaysBaby (BEHAVIORAL).
Who is sponsoring clinical trial NCT06618586?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06618586 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infant Death
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06618586's enrollment target sits among peer trials
10,000 14th of 2000 higher than 1,985 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI